Take a look at this month’s industry headlines including FDA warnings over hepatitis C drugs in patients with liver injury, a new infectious diseases strategy for the UK and priority review for Merck’s Ebola vaccine.
Researchers at Dartmouth’s Geisel School of Medicine have found that hypoxic conditions are linked to a hypoxia-typic morphotype of the pathogen Aspergillus fumigatus. This morphotype worsens the diseases progression of invasive aspergillosis in a murine model.
Researchers have discovered that successful enterovirus infection could depend on the presence of a single protein in the host. Temporarily disabling this single protein could protect humans from the common cold and other viral diseases.
New research has suggested that an inherited genetic trait appears to protect some individuals against MRSA infections.
Researchers have discovered that a relatively ancient drug efflux pump from Haemophilus influenzae exports the same antibiotics as its evolved counterpart from Escherichia coli, but was mitigated by a leaky porin channel.
Scientists investigating increased scarlet fever cases have identified that a new dominant linage of Strep A with increased toxin production has emerged.
Researchers have uncovered the mechanism used by predatory bacteria, Bdellovibrio bacteriovorus, to initiate prey invasion.
Researchers have developed an animal model mimicking HIV infection in infants, potentially allowing the development of therapeutics and interventions for the pediatric population.